An alternative transcript of the rat renin gene was recently characterized in the adrenal gland, in addition to the known messenger RNA (mRNA) coding for preprorenin. In the alternative transcript, exon 1 is replaced by exon 1A, a domain originating in intron 1. The reading frame of this mRNA, termed exon 1A-renin transcript, codes for a truncated prorenin that presumably remains intracellular, in contrast to preprorenin, which is targeted to the secretory pathway by its prefragment. We here demonstrate the tissue-specific regulation of expression of both transcripts by RT and PCR. In many tissues both transcripts are present, for example in the adrenal gland, spleen, liver, and hypothalamus. In some organs, however, only one of the renin mRNAs is found. In the kidney only the full-length mRNA coding for preprorenin is detected. In the heart exclusively the exon 1A-mRNA is expressed, but not the preprorenin transcript. After myocardial infarction, which is known to activate the intracardiac renin-angiotensin system, expression of exon 1A-renin mRNA in the left ventricle was stimulated about 4-fold, compared with that in sham-operated animals, whereas no mRNA corresponding to preprorenin was detectable. These findings may have implications for the current concepts of local extrarenal renin-angiotensin systems, as they provide the molecular basis for a possible intracellular function of renin and exclude a role for locally produced secretory renin in the
renin mRNAs is found. In the kidney only the full-length mRNA coding for preprorenin is detected. In the heart exclusively the exon 1A-mRNA is expressed, but not the preprorenin transcript. After myocardial infarction, which is known to activate the intracardiac renin-angiotensin system, expression of exon 1A-renin mRNA in the left ventricle was stimulated about 4-fold, compared with that in sham-operated animals, whereas no mRNA corresponding to preprorenin was detectable. These findings may have implications for the current concepts of local extrarenal renin-angiotensin systems, as they provide the molecular basis for a possible intracellular function of renin and exclude a role for locally produced secretory renin in the heart. (Endocrinology 141: [2963] [2964] [2965] [2966] [2967] [2968] [2969] [2970] 2000) R ENIN, THE KEY enzyme of the renin-angiotensin system (RAS), is generally known as a secretory protein, which is synthesized and secreted predominantly by the kidney. Preprorenin is cotranslationally targeted to the endoplasmic reticulum, where the prefragment containing the signal sequence is cleaved. The resulting prorenin represents an inactive precursor, which is either released constitutively or processed to active renin and secreted in a regulated manner from storage granules (1) .
Recently, we characterized an alternative transcript of the rat renin gene in the adrenal gland (2) . In contrast to the full-length transcript coding for preprorenin, the alternative transcript lacks exon 1, containing the coding sequence of the prefragment. Instead, exon 2 is preceded by a domain of about 80 nucleotides, designated exon 1A, which originates in intron 1. The intervening sequence of intron 1, which has been excised, shows all essential sequence elements defining an as yet unidentified splice site. Thus, we concluded that this transcript, termed exon 1A-renin messenger RNA (mRNA), represents an alternatively spliced transcript, probably arising from an additional transcription start in intron 1. Our findings are supported by Lee-Kirsch et al. (3) , who identified a similar transcript in the rat brain. The open reading frame of the alternative mRNA can result in a truncated prorenin, which is not targeted to the secretory pathway but remains intracellular (3) . Indeed, we and others demonstrated the presence of renin within adrenal mitochondria (4, 5) . Furthermore, mitochondria isolated from the adrenal gland specifically import the truncated prorenin coded by the exon 1A mRNA (2) . Therefore, this form of renin might be a component of an intracellular RAS in extrarenal tissues.
These findings may change our current concepts about local renin-angiotensin systems, which have been suggested to exist in a number of tissues, such as adrenal gland, brain, and heart (6). There is evidence for a functional active RAS in the adrenal gland and the brain, where inhibitors of the RAS exert specific functions even in the absence of circulating renin (7) (8) (9) . In these as well as in other tissues, expression of the renin gene has been shown (6, 10, 11) . A functional RAS and local expression of the renin gene in the heart are still controversial (6) . Previous analyses of the expression of the renin gene in extrarenal tissues, however, did not differentiate between the full-length transcript and the exon 1A variant. Information about the tissue-specific distribution of the two renin transcripts would be of importance to gain further insight into the function of local RASs.
We therefore decided to reinvestigate the expression of the renin gene in various rat tissues, based on RT-PCR, which allows us to discriminate between the two forms of the renin transcript. Furthermore, as our observations suggested that exon 1A-renin is the only form of renin expressed in the heart under basal conditions, we additionally analyzed the ex-pression of the two renin transcripts in the rat heart after myocardial infarction.
Materials and Methods

Isolation of RNA
Sprague Dawley rats, weighing 200 -300 g, were used in the experiments. Rats were housed under alternating 12-h light, 12-h dark cycles at a temperature between 20 and 22 C and were fed the standard laboratory diet (Ssniff, Soest, Germany) with free access to tap water. Animal experimentation was performed according to the federal and local laws as well as institutional regulations. Rats were killed by cervical dislocation under nembutal (60 mg/kg) anesthesia. Tissues were removed and immediately frozen in liquid nitrogen. Total RNA was isolated from the various tissues by the method of Auffray and Rougeon (12) .
RT-PCR
RT was performed using Superscript II reverse transcriptase (Life Technologies, Inc., Karlsruhe, Germany) with 5 g of each RNA and an oligo(deoxythymidine) primer containing two degenerate nucleotide positions at its 3Ј-end for complementary DNA (cDNA) synthesis.
Amplification of the cDNAs corresponding to the full-length or the alternative transcript of the renin gene was performed by nested PCR based on four sets of primers (Life Technologies, Inc., Karlsruhe, Germany); the antisense primers used for the first and second amplifications, Ren25 [5Ј-GTCACTGGGTGACAGAGGAGC-3Ј; nucleotides 10848 -10868 (13)] and Ren22 (5Ј-GCATGATCAACTGCAGGGAGCTG-3Ј; 9601-9623), respectively, were identical for both transcripts (Fig. 1) . Discrimination of the cDNAs derived from the full-length transcript and the mRNA variant was achieved by using different sense primers; Ren6 (5Ј-GGAGGAGGATGCCTCTCTGGGCA-3Ј; 40 -62) and Ren24 (5Ј-TCAGTCTCCCGACAGACACAG-3Ј; 91-111) for the first and second amplifications yielded a fragment corresponding to the full-length transcript, whereas Ren33 (5Ј-CTTGAATTTCCCCAGTCAGTG-3Ј; 3865-3885)and Ren23 (5Ј-GTGATGCATTGGAGGACAACTG-3Ј; 3883-3904) hybridized specifically to the cDNA derived from the exon 1A-renin transcript. Sequences complementary to the inner primers Ren24/ Ren22 or Ren23/Ren22 were separated by six introns or by five introns and about 680 nucleotides of the 3Ј-region of intron 1, respectively, and were 9.5 or 5.7 kb apart in the genomic DNA. Fragments derived from the cDNAs were expected to be 855 and 849 bp in size for the inner primers Ren24/Ren22 and Ren23/Ren22, respectively.
For an internal control the cDNA derived from the glyceraldehyde-3-phosphate dehydrogenase (GAP-DH) transcript was used. The sense primers were G3 (5Ј-ATGGTGAAGGTCGGTGTGAA-3Ј) and G1 (5Ј-TGCCATCACTGCCACTCAGAAG-3Ј); the antisense primers were G4 (5Ј-CTCCTTGGAGGCCATGTAGG-3Ј) and G2 (5Ј-CATAC-CAGGAAATGAGCTTCAC-3Ј). Primers G3 and G4 gave rise to a fragment of 999 bp in the first amplification; the second amplification using primers G1 and G2 resulted in a fragment of 407 bp.
Amplification was performed using Taq DNA polymerase (Promega Corp., Mannheim, Germany) starting with 2 l of the 20-fold diluted cDNAs as a template for the first amplification over 30 cycles in a total volume of 50 l, using the outer primer pairs. Aliquots of the first PCR reactions were diluted 50-fold, and 2 l were then used for the following second amplification for another 30 cycles in the presence of the respective inner primer pairs. As GAP-DH is expressed to a much greater extent than renin, the primers for amplification of GAP-DH were added to each PCR after 10 cycles, so that amplification of GAP-DH ran over 20 cycles in both the first and second amplifications. Parallel samples with no reverse transcriptase served as a negative control. PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining. The nucleotide sequences of the fragments obtained by reninspecific primers were confirmed by direct sequence analysis.
For each tissue, samples from three animals were analyzed, and each PCR was repeated twice.
Induction of myocardial infarction and sham surgery
Myocardial infarction was induced in male SHR rats (250 -300 g) by permanent ligation of the left descending coronary artery by a modified technique described by Johns and Olson (14) . Briefly, after induction of anesthesia with an ip injection of chloral hydrate, rats were intubated, artificially ventilated, and connected to an electrocardiogram recorder for continuous monitoring during surgery. A left thoracotomy was performed by cutting the third and fourth ribs, and a rib-spreading chest retractor was inserted. Then, the left descending coronary artery was ligated intrathoracically with a sterile suture (Ethibond 6 -0, Ethicon, Somerville, NJ) under a stereomicroscope. Successful ligation of the coronary artery was verified by the occurrence of arrhythmia in the electrocardiogram and visually by hypomotility and change of color in the ischemic area. In rats receiving sham surgery, the ligation was placed beside the coronary artery. Finally, the thoracic cavity was closed during respiration hold, and analgesia was induced by sc injection of buprenorphin-HCl (0.2 mg/kg).
Four and 5 days after coronary ligation, rats were killed, and the
FIG. 1. Primers designed for
RT-PCR to detect the cDNAs derived from the transcripts coding for preprorenin and exon 1A-renin. R6 and R25, Outer primer pair for amplification of the preprorenin cDNA; R24 and R22, inner primer pair for amplification of the preprorenin cDNA; R33 and R25, outer primer pair to perform a PCR specific for exon1A-renin; R23 and R22, inner primer pair to perform a PCR specific for exon1A-renin. Nucleotides are numbered according to Fukamizu et al. (13) . Exons are not drawn to scale.
hearts were excised immediately. After removal of the large vessels, the atria and ventricles were separated, and tissues were immediately frozen in liquid nitrogen.
Semiquantitative RT-PCR analysis of renin transcripts after myocardial infarction
RNA was prepared from left and right ventricles, left and right atria, and septum of the infarcted hearts and controls as described above. RT was performed as described, using 2 g RNA for each tissue.
A semiquantitative RT-PCR was performed using the respective inner primer pairs for exon 1A-renin (Ren23/Ren22) and GAP-DH (G1/ G2). First, for both templates the number of cycles was determined, which is required to obtain a signal visible on an ethidium bromidestained agarose gel and still remain in the linear range of the reaction. For exon 1A-renin, this value was 38 cycles, whereas for GAP-DH this was achieved at 22 cycles (Fig. 2) . These conditions were chosen for further analysis. For preprorenin, quantification could not be performed, because there was no signal at all.
PCR products were separated on agarose gels stained with ethidium bromide, and the intensities of the bands were evaluated with imaging software TINA (Raytest Isotopenmessgeräte, Straubenhardt, Germany). For calculation of relative amounts, values obtained for exon 1A-renin mRNA were normalized to the respective GAP-DH bands after corrections for background.
Tissues from four animals of each group were analyzed; each RT-PCR was repeated twice. PCR products to be compared were analyzed on the same gel. To evaluate differences between the groups, the Mann-Whitney test was performed. Only P Ͻ 0.05 was considered significant.
Results
Expression of preprorenin and exon 1A-renin in different rat tissues
For the specific amplification of cDNAs derived from either the full-length mRNA or the exon 1A-renin transcript, two pairs of nested primers for each of the cDNAs were designed (Fig. 1) . Although the antisense primers were identical (the outer primer being located immediately downstream of the stop codon and the inner primer hybridizing in exon 7), the sense primers were chosen to distinguish both transcripts. One set of sense primers was complementary to sequences in exon 1, and the other set hybridizes to the region of intron 1 termed exon 1A, which is found in the alternative transcript instead of exon 1. Therefore, using the respective pairs of nested primers for two successive amplifications, we were able to clearly distinguish both mRNAs. This RT-PCR, however, was not designed to perform an exact quantification, as we were more interested in a qualitative analysis of the tissue-specific expression of both mRNAs.
In many of the tissues analyzed both transcripts were found ( Fig. 3 ; summarized in Table 1 ), represented by a PCR product of 855 bp for the preprorenin transcript and 849 bp for the exon 1A-renin mRNA, respectively. Both transcripts were expressed in adrenal gland, spleen, thymus, liver, and stomach as well as in the reproductive organs, namely uterus, ovary, and testis. There were also some tissues of the brain, namely hypothalamus, cerebellum, medulla oblongata, and pituitary, which contained both transcripts. Interestingly, in several tissues exclusively one of the two renin transcripts could be detected, demonstrating a tissuespecific regulation of expression. In the kidney and both the small and large intestines exclusively the full-length mRNA was found. In the heart, which was separated into right and left ventricles and atria, as well as in the lung, no preprorenin transcript was detected. In these tissues the exon 1A variant was the only transcript of the renin gene.
In the aorta, thyroid gland, and submandibular gland no mRNA of the renin gene was detected.
The levels of the PCR product of GAP-DH with a size of 407 bp, which was used for an internal control, were similar in most tissues analyzed, as expected. When the GAP-DH primers were included in the parallel reactions specific for the preprorenin and the exon 1A transcript, respectively, the bands derived from GAP-DH were equivalent. In thyroid gland, submandibular gland, and intestine, the two successive amplifications of GAP-DH over 20 cycles each resulted in weak, but equal, signals.
In the negative control samples receiving no reverse transcriptase no PCR product derived from either renin or GAP-DH was seen (data not shown).
Expression of renin after myocardial infarction
The results of our RT-PCR analysis revealed the expression of exon 1A-renin, but not preprorenin in the rat heart. Earlier studies reported an increase in renin gene expression in the heart after myocardial infarction (15) . This, therefore, raised the question of which form of renin is induced under these conditions: exon 1A-renin, preprorenin, or both.
Rat hearts, separated into right and left ventricles, right and left atria, and septum, were analyzed 4 and 5 days after myocardial infarction. On semiquantitative RT-PCR, a 4-fold increase in exon 1A-renin mRNA in the infarcted left ventricle after 4 days was observed compared with left ventricles of sham-operated control animals, in which a signal for exon 1A-renin was hardly visible with 38 cycles of amplification   FIG. 2 . Determination of the number of cycles required for quantification of exon 1A-renin mRNA in the left ventricle (LV) of the rat heart of control animals (Co), 4 days (4d) and 5 days (5d) after myocardial infarction. Ethidium bromide-stained agarose gel of the amplified cDNAs. RT-PCR was performed as described in Materials and Methods for 36, 38, 40, and 42 cycles. N, Negative control samples receiving no reverse transcriptase; M, mol wt marker; 1A, fragment corresponding to exon 1A-renin; GAP, fragment corresponding to GAP-DH. (Fig. 4) . Five days after myocardial infarction, the amount of exon 1A-renin mRNA decreased again. The mRNA coding for preprorenin was still not detected, even by RT-PCR of 38 cycles (not shown) or by the nested PCR used for the tissuespecific analysis, which comprises 2 successive PCRs with 30 cycles each (Fig. 4) . A distinct increase in the level of exon 1A-renin transcript also was observed in the right and left atria, but these differences proved to be significant in the right atrium only (Fig.  5) . In contrast, in the right ventricle (Fig. 5 ) and the septum (not shown) no significant changes in the amount of exon 1A-renin transcript were found. Preprorenin mRNA was not detectable in any of the heart tissues. No PCR product was found in the negative control samples that did not receive reverse transcriptase (examples shown in Fig. 4) .
Discussion
In the present study we demonstrate the expression of a newly discovered alternative transcript of the rat renin gene (2, 3) in various tissues by means of RT-PCR compared with the expression of the known preprorenin mRNA. The alternative transcript, termed exon 1A-renin mRNA, which we originally found in the adrenal gland, lacks exon 1 containing the coding sequence for the prefragment. Exon 1 in this mRNA is replaced by exon 1A, a domain originating in intron 1. The latter mRNA thus codes for a truncated prorenin that cannot be targeted to the secretory pathway and thus most likely remains intracellular. Previous studies of renin gene expression did not take into account the existence of the second renin transcript.
The present analysis extends our recent report by demonstrating the presence of the alternative transcript in many tissues, either in addition to or instead of the known preprorenin mRNA. Both transcripts are found to be expressed, for example, in liver, spleen, hypothalamus, pituitary, testis, ovary, or adrenal gland, whereas in the kidney and intestine exclusively the full-length mRNA was detected. In the latter organs, therefore, the secretory protein appears to be the only form of renin, whereas in the former tissues an additional intracellular renin may be synthesized. Interestingly, in the heart, in both ventricles and atria, and in the lung, the exon 1A-renin mRNA proved to be the only transcript of the renin gene, whereas the transcript coding for preprorenin was absent.
The finding that in the heart exclusively the exon 1A variant is transcribed from the renin gene was rather surprising, as the current hypothesis of a local RAS in this organ is based on the assumption of the presence of a secretory renin. In the Uterus   FIG. 4 . Analysis of the expression of exon 1A-renin and preprorenin mRNA in the left ventricles (LV) of the hearts of four rats (no. 1-4) in each group: control animals (Co) and 4 days (4d) and 5 days (5d) after myocardial infarction. Ethidium bromide-stained agarose gels of the amplified cDNAs are shown. For exon 1A-renin mRNA the RT-PCR was run over 38 cycles; for preprorenin mRNA a nested PCR was performed (for details, see Materials and Methods). N, Negative control samples receiving no reverse transcriptase; P, positive control (cDNA from adrenal gland); M, mol wt marker; 1A, fragment corresponding to exon 1A-renin; GAP, fragment corresponding to GAP-DH.
adult rat heart, renin gene expression has been investigated in many studies by RT-PCR, Northern blot, and ribonuclease protection assay (10, 11, (15) (16) (17) (18) (19) (20) (21) (22) (23) , but results were controversial. Although in several studies the presence of renin mRNA was demonstrated (15, 16 -19) , others failed to detect any transcript of the renin gene under nonstimulated conditions (10, 11, 20, 21) or signals were nearly at the limit of detection (22, 23) . Our findings clearly demonstrate the expression of the exon 1A-mRNA in the hearts of Sprague-Dawley rats under nonstimulated conditions and exclude the presence of the transcript coding for preprorenin. We suppose that in former studies demonstrating renin expression in the adult rat heart, the exon 1A variant has been detected and not the known preprorenin transcript, as the methods used were not designed to distinguish between mRNA species. Furthermore, the question arises of which transcript is expressed in the adult rat heart under stimulatory conditions, as in these studies again renin mRNA amounts have been quantified by RT-PCR using primers in exon 6 or 7 and exon 9, and this mRNA inevitably was assumed to represent the known preprorenin transcript. Stimulation of renin gene expression has been demonstrated to occur during hypertrophy (18, 19) and after myocardial infarction (15) . Here, the highest concentrations of renin mRNA were measured 4 days after myocardial infarction. Days 4 and 5 after infarction were therefore chosen in our experiments to identify the renin transcript being stimulated under these conditions. Our results clearly show that the intracardiac activation of the renin gene is confined to the exon 1A-renin variant, whereas the mRNA coding for preprorenin remains undetectable. Consequently, the synthesis of preprorenin and its subsequent secretion as active renin by the heart are excluded. We did not determine which cells in the heart express the exon 1A-renin transcript; however, it has been reported that both isolated rat cardiomyocytes and fibroblasts are able to produce angiotensin I (24) .
The local generation of angiotensin II in the heart has been suggested to be involved in the ventricular remodeling after myocardial infarction (25) . In agreement with this hypothesis, it has been observed that myocardial infarction is followed by increased angiotensin-converting enzyme (ACE) gene expression and that both renin mRNA and ACE mRNA are localized in the border zone of the infarcted area (15, 26) . Localization of renin mRNA has been shown by in situ hybridization using a probe complementary to exons 6 -9, which was not specific for the preprorenin sequence (15) . Our data now allow the conclusion that the renin mRNA detected in the border zone of the infarcted region corresponds to exon 1A-renin mRNA and not to the known preprorenin transcript, as exclusively the exon 1A-renin variant was detected by RT-PCR. Angiotensinogen gene expression in the heart has been demonstrated as well (15, 27) . In addition, ventricular remodeling was prevented by ACE inhibition and AT1 receptor blockade (28) . The specific role of intracellular renin and thus possibly intracellular generation of angiotensin in the postinfarction processes remain to be investigated. The results of the RT-PCR also show an increase in exon 1A-renin mRNA in the atria, possibly due to the volume overload, which is associated with myocardial infarction in the left ventricle and is known to activate the cardiac RAS (29, 30) .
Our data on renin expression are supported by the observation that cardiac renin activity as well as concentrations of both angiotensin I and angiotensin II are increased after myocardial infarction (31, 32) . However, this activation of the cardiac RAS cannot definitely be ascribed to local intracardiac synthesis of the enzyme. The analysis of cardiac renin activity is complicated by the dual origin of renin in the heart. Several findings indicate an uptake of renin into the heart from the plasma (33) (34) (35) , but it has not been determined whether renin uptake is increased after myocardial infarction. Therefore, as PRA is known to increase acutely after myocardial infarction, it is conceivable, that uptake of renin from the plasma may contribute to the observed increase in intracardiac renin activity after myocardial infarction. Subcellular fractionation of normal rat hearts revealed renin activity associated with the endosomal compartment as well as the mitochondrial fraction (Peters, J., unpublished results); the latter is in agreement with our earlier observation that a protein corresponding to exon 1A-renin is transported into isolated mitochondria (2) .
The exon 1A-transcript was also found to be expressed in several brain regions. In medulla oblongata, cerebellum, and hypothalamus it was detected in addition to the full-length transcript. Renin expression in these tissues has been described previously, and the presence of angiotensinogen and ACE in the brain has been proved as well (6, 10, 11, 22, 36 -38) . Nevertheless, evidence is still lacking that all components of a functional RAS are present within a single cell. Therefore, it has been suggested that angiotensin II in the brain is generated extracellularly. This is supported by the detection of the transcript coding for preprorenin in the present study. Although our results cannot prove the existence of a local RAS within the same cell of brain tissues, they additionally provide the possibility of an intracellular generation of angiotensins in the brain.
Our results are apparently in contrast to the findings of Lee-Kirsch et al. (3) , who described the expression of the exon 1A-mRNA to be restricted to the brain, in which they did not detect the preprorenin transcript by ribonuclease protection assay. These contradictory data may be due to the higher sensitivity of the RT-PCR we performed.
Although the biochemical properties of the protein encoded by the exon 1A-mRNA are still under investigation, it is tempting to speculate that this form of renin is a component of an intracellular RAS. In those tissues expressing the preprorenin transcript as well as the exon 1A-mRNA, like adrenal gland, liver, or hypothalamus, therefore, both a secretory and an intracellular system may exist. This hypothesis is supported by the fact that in the adrenal gland renin has been detected immunocytochemically and biochemically both within cytoplasmic vesicles for storage and regulated secretion (39, 40) and within mitochondria in the zona glomerulosa (4, 41) . In the adrenal, renin was detected in mitochondrial inclusion bodies of high electron density. We have also shown that these dense bodies, in contrast to the cytoplasmic granules of the kidney and adrenal gland, do not contain lysosomal enzymes, such as cathepsins (4) . Interestingly, both mitochondrial renin and the number of dense bodies are increased by nephrectomy, and this is associated with an increase in aldosterone production, which partly takes place within mitochondria. Therefore, a possible role of intramitochondrial renin in the regulation of steroid biosynthesis is suggested (4, 7) .
The findings presented here show that our concepts about local RASs need to be redefined, because in some systems, such as the intracardiac RAS, local expression of secretory renin is clearly excluded. In addition, our findings offer a new molecular basis for the existence of an intracellular RAS, which has been previously proposed by Mulrow (42) .
